A novel non-invasive diagnostic imaging technique of metastatic cancer using plasminogen activator inhibitor type 2.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/354125

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project aims to develop a non-invasive tumour diagnostic imaging agent based on a non-toxic protein (PAI2) that we know specifically identifies a critical marker of malignancy. PAI2 will be labelled with commonly used imaging radioisotopes. This novel imaging technique has important potential clinical uses including, determination of the most appropriate treatment for individual patients, assessing the success of such treatments, and a novel non-invasive prognostic indicator of malignancy.

Funded Activity Details

Start Date: 01-01-2005

End Date: 01-01-2005

Funding Scheme: NHMRC Development Grants

Funding Amount: $187,750.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Radiology and Organ Imaging

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Diagnostic imaging | Serpins | Tumour metastases | Urokinase | plasminogen

Related Links